Indivior Pharmaceuticals (INDV) Earnings Date & Reports

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INDV is expected to report earnings to fall 22.66% to 74 cents per share on July 30

Indivior Pharmaceuticals INDV Stock Earnings Reports

Q2'26

Est.

$0.74

Q1'26

Beat

by $0.30

Q4'25

Beat

by $0.15

Q3'25

Beat

by $0.33

Q2'25

Beat

by $0.27

The last earnings report on April 30 showed earnings per share of 95 cents, beating the estimate of 66 cents. With 1.64M shares outstanding, the current market capitalization sits at 4.52B.

View a ticker or compare two or three

Compare

INDV

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for INDV